Rotavirus Vaccine Development
Candidate rotavirus vaccines derived from neonatal strains developed
Published in Medical Letter on the CDC and FDA, October 23rd, 2005
"The need for a rotavirus vaccine in India is based on the enormous burden associated with the 1100,000 deaths due to rotavirus diarrhea that occur annually among Indian children. Two rotavirus strains identified during nosocomial outbreaks of rotavirus infection in New Delhi and Bangalore, India, more than a decade ago are being developed as live oral vaccines," scientists in the United States and India report.
"Infected newborns had no symptoms, shed virus for up to 2 weeks after infection, mounted a robust immune response, and demonstrated protection...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Breast Cancer Prognosis
Obesity increases mortality risk in women with breast cancer - HIV/AIDS Diagnosis
Rapid HIV antibody assays for detecting recent seroconversion modified - Smallpox Vaccine
Outcome of smallpox vaccination in healthcare workers described - West Nile Virus
Immunoassay to detect anti-West Nile virus IgM antibodies developed - Allergy Medicine
Bifidobacterium bifidum G9-1 suppresses IgE production - Amyotrophic Lateral Sclerosis
CytRx initiates phase II clinical trial with arimoclomol for treating ALS - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
